Anne May on the Cost Effectiveness of an Exercise Program for Patients With Metastatic Breast Cancer
A supervised exercise already shown to alleviate fatigue and other side effects in patients with metastatic breast cancer has now been found to also be cost analysis. Anne May, PhD, of Utrecht ...
Metronomic Capecitabine Plus Aromatase Inhibitor as Initial Therapy in Patients With Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Metastatic Breast Cancer: The Phase ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results